EurekaMag.com logo
+ Translate

Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo


, : Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo. Blood 91(8): 2672-2678

It is still uncertain whether multilineage hematopoietic progenitor cells are affected by human immunodeficiency virus-1 (HIV-1) infection in vivo. The SCID-hu Thy/Liv model is permissive of long-term multilineage human hematopoiesis, including T lymphopoiesis. This model was used to investigate the effects of HIV-1 infection on early hematopoietic progenitor function. We found that both lineage-restricted and multilineage hematopoietic progenitors were depleted from grafts infected with either a molecular clone or a primary isolate of HIV-1. Depletion of hematopoietic progenitors (including CD34(+) cells, colony-forming units in methylcellulose, and long-term culture-initiating cells) occurred several days before the onset of thymocyte depletion, indicating that the subsequent rapid decline in thymocyte numbers was due at least in part to loss of thymocyte progenitors. HIV-1 proviral genomes were not detected at high frequency in hematopoietic cells earlier than the intrathymic T-progenitor cell stage, despite the depletion of such cells in infected grafts. Proviral genomes were also not detected in colonies derived from progenitor cells from infected grafts. These data demonstrate that HIV-1 infection interrupts both lineage-restricted and multilineage hematopoiesis in vivo and suggest that depletion of early hematopoietic progenitor cells occurs in the absence of direct viral infection.

(PDF 0-2 workdays service)

Accession: 003162932

PMID: 9531575

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Koka, P.S.; Fraser, J.K.; Bryson, Y.; Bristol, G.C.; Aldrovandi, G.M.; Daar, E.S.; Zack, J.A., 1998: Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo. Human immunodeficiency virus type 1 (HIV-1)-infected individuals often exhibit multiple hematopoietic abnormalities reaching far beyond loss of CD4(+) lymphocytes. We used the SCID-hu (Thy/Liv) mouse (severe combined immunodeficient mouse transpla...

Kitchen, S.G.; Killian, S.; Giorgi, J.V.; Zack, J.A., 2000: Functional reconstitution of thymopoiesis after human immunodeficiency virus infection. We have utilized combination antiretroviral therapy following human immunodeficiency virus type 1-induced human CD4(+) thymocyte depletion in the SCID-hu mouse to examine the immune competence of reconstituting thymocytes which appear following ad...

Gautier, D.; Beq, Séphanie.; Cortesão, C.S.; Sousa, A.E.; Cheynier, Rémi., 2007: Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection. Human immunodeficiency virus type 2 (HIV-2) infection leads to a lifelong asymptomatic period in the majority of patients. Even in patients with progressive disease, a slow CD4 count decline characterizes the chronic phase of HIV-2 infection, sug...

Rulli, K.; Lenz, J.; Levy, L.S., 2002: Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus. A time course analysis of SL3-3 murine leukemia virus (SL3) infection in thymus and bone marrow of NIH/Swiss mice was performed to assess changes that occur during the early stages of progression to lymphoma. Virus was detectable in thymocytes, bo...

Donahue R.E.; Johnson M.M.; Zon L.I.; Clark S.C.; Groopman J.E., 1987: Suppression of in vitro hematopoiesis following human immunodeficiency virus hiv infection. Journal of Cellular Biochemistry Supplement (11 PART D): 51

Donahue R.E.; Johnson M.M.; Zon L.I.; Clark S.C.; Groopman J.E., 1987: Suppression of in vitro hematopoiesis following human immunodeficiency virus infection. Nature (London) 326(6109): 200-203

Akiyama, H.; Ido, E.; Akahata, W.; Kuwata, T.; Miura, T.; Hayami, M., 2003: Construction and in vivo infection of a new simian/human immunodeficiency virus chimera containing the reverse transcriptase gene and the 3' half of the genomic region of human immunodeficiency virus type 1. A new simian/human immunodeficiency virus (SHIV) chimera with the reverse transcriptase (RT)-encoding region of pol, in addition to the 3' region encoding vpr, vpu, tat, rev, env and nef of HIV-1, on an SIV(mac) (SIV from a macaque monkey) ba...

Akiyama, H.; Ido, E.; Miura, T.; Hayami, M., 2002: Construction and in vivo infection of a new simian/human immunodeficiency chimeric virus having broader regions derived from human immunodeficiency virus type 1. Journal of Medical Primatology 31(4-5): 274, August

Eda, Y.; Murakami, T.; Ami, Y.; Nakasone, T.; Takizawa, M.; Someya, K.; Kaizu, M.; Izumi, Y.; Yoshino, N.; Matsushita, S.; Higuchi, H.; Matsui, H.; Shinohara, K.; Takeuchi, H.; Koyanagi, Y.; Yamamoto, N.; Honda, M., 2006: Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection. In an accompanying report (Y. Eda, M. Takizawa, T. Murakami, H. Maeda, K. Kimachi, H. Yonemura, S. Koyanagi, K. Shiosaki, H. Higuchi, K. Makizumi, T. Nakashima, K. Osatomi, S. Tokiyoshi, S. Matsushita, N. Yamamoto, and M. Honda, J. Virol. 80:5552-...

Goldstein, H.; Pettoello-Mantovani, M.; Anderson, C.M.; Cordelier, P.; Pomerantz, R.J.; Strayer, D.S., 2002: Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue. To evaluate the in vivo efficacy of gene therapy for treating human immunodeficiency virus type 1 (HIV-1) infection, a novel simian virus (SV) 40-derived vector gene delivery system that efficiently transduces human leukocytes was combined with a...